Synthesis of the C-terminal domain of the tissue inhibitor of metalloproteinases-1 (TIMP-1). 2003

József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
Research Group for Peptide Chemistry, Hungarian Academy of Sciences, Eötvös Loránd University, H-1518 Budapest 112 PO Box 112, Hungary.

According to recent investigations, the C-terminal domain of the tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) is responsible for some biological effects that are independent of the enzyme-inhibiting effect of the N-terminal domain of the molecule. The C-terminal domain has been prepared for structure-biological activity investigations. After the chemical synthesis and the folding of the linear peptide. LC-MS and MALDI-MS analysis revealed that two isomers with different disulphide bond arrangements were formed. Since more than 30 folding experiments resulted in products with a very similar HPLC-profile, it was concluded that in the absence of the TIMP-1 N-terminal domain no entirely correct folding of the C-terminal domain occurred. Furthermore, it was observed that, in spite of several purification steps, mercury(II) ions were bound to the 6SH-linear peptide; it was demonstrated--using disulphide bonded TIMP-1(Cys145-Cys166) as a model--that mercury(II) ions can cause peptide degradation at pH 7.8 as well as in 0.1% trifluoroacetic acid.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D017669 Mercury Compounds Inorganic compounds that contain mercury as an integral part of the molecule. Compounds, Mercury
D019032 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample-matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced, and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. Laser Desorption-Ionization Mass Spectrometry, Matrix-Assisted,MALD-MS,MALDI,Mass Spectrometry, Matrix-Assisted Laser Desorption-Ionization,Mass Spectroscopy, Matrix-Assisted Laser Desorption-Ionization,Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry,Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization,MALDI-MS,MS-MALD,SELDI-TOF-MS,Surface Enhanced Laser Desorption Ionization Mass Spectrometry,Laser Desorption Ionization Mass Spectrometry, Matrix Assisted,MALDI MS,Mass Spectrometry, Matrix Assisted Laser Desorption Ionization,Mass Spectroscopy, Matrix Assisted Laser Desorption Ionization,Matrix Assisted Laser Desorption Ionization Mass Spectrometry
D019715 Tissue Inhibitor of Metalloproteinase-1 A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a N-glycosylated protein, molecular weight 28 kD, produced by a vast range of cell types and found in a variety of tissues and body fluids. It has been shown to suppress metastasis and inhibit tumor invasion in vitro. TIMP-1,Metalloproteinase-1 Tissue Inhibitor,Tissue Inhibitor of Metalloproteinase 1

Related Publications

József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
October 1998, Biochimica et biophysica acta,
József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
August 1997, The Journal of biological chemistry,
József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
May 2008, Molecular bioSystems,
József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
July 1994, The Journal of biological chemistry,
József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
January 1993, The Biochemical journal,
József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
April 1996, FEBS letters,
József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
February 1991, The Journal of biological chemistry,
József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
September 2001, FEMS microbiology letters,
József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
September 2011, Matrix biology : journal of the International Society for Matrix Biology,
József Bódi, and Nikolett Mihala, and Andrea Hajnal, and Katalin F Medzihradszky, and Helga Süli-Vargha
October 1995, Neurologia medico-chirurgica,
Copied contents to your clipboard!